Feature

Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis

Publish date: June 1, 2023

 

FROM ARTHRITIS & RHEUMATOLOGY

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

New data forecast more oral PDE4 inhibitors for psoriasis
MDedge Internal Medicine
Air pollution may be causing eczema
MDedge Internal Medicine
Topical delgocitinib shows promise for chronic hand eczema, pivotal trial shows
MDedge Internal Medicine
JAK inhibitor ivarmacitinib shows efficacy for atopic dermatitis in a pivotal trial
MDedge Internal Medicine
What are the clinical implications of recent skin dysbiosis discoveries?
MDedge Internal Medicine
Study focuses on adolescent data in upadacitinib AD trials
MDedge Internal Medicine
Facial, hand, and foot dermatitis: Lebrikizumab and dupilumab show efficacy in new studies
MDedge Internal Medicine
Expunging ‘penicillin allergy’: Your questions answered
MDedge Internal Medicine
Can online mindfulness and self-compassion training improve quality of life for patients with atopic dermatitis?
MDedge Internal Medicine
JAK-inhibitor safety in adolescents with AD: Long-term analyses reported
MDedge Internal Medicine